The Christie: Sarah Harding breast cancer study spots 88 women at risk
A breast cancer study created in memory of Girls Aloud singer Sarah Harding has already helped identify more than 80 young women who are at risk of developing breast cancer.The Breast Cancer Risk Assessment in Young Women (BCAN-RAY) study was set up in May 2023 inspired by the singer's desire to find new ways of spotting the disease earlier.Harding, of Stockport, died in 2021 at the age of 39.The second phase of the study involves setting up the Sarah Harding Young Women's Breast Cancer Fellowship, which will include a research lab dedicated to examining the factors which put younger women at risk.
BCAN-RAY, which is funded by The Christie Charity, Cancer Research UK, and The Shine Bright Foundation, is one of the world's first research programmes to identify breast cancer risks in younger women without a family history of the disease.Led by Dr Sacha Howell, who was Harding's consultant while she was receiving treatment at The Christie, the study focusses on exploring risk factors and creating personalised early screening options for women as young as 30. He said: "Breast cancer is the biggest killer of women aged 35-50 in the UK but if you pick it up early enough you don't die from it."
'Shock and devastation'
"This research isn't about prolonging people's lives for a year or two. It's about curing people so they can live full lives with their loved ones," he said.Dr Howell said Harding's wish was that "no other young woman should experience the shock and devastation of a breast cancer diagnosis" when they had no reason to think they were at risk."Eventually we would like to see the risk prediction for breast cancer in young women rolled out across the UK so we can reduce the number of deaths and improve lives," he said."The fellowship will bring us a step closer to achieving Sarah's goal."Currently, breast screening in the UK starts at age 50, with women invited for routine checks every three years. The BCAN-RAY study identifies younger women at risk and provides them with early intervention.The study, which includes questionnaires, genetic testing and low-dose mammograms, has already recruited 500 women aged 30 to 39, with another 500 to be recruited. Of the first 500, 88 have been identified as being at increased risk, with 58 of those having phone consultations to discuss ways to reduce their risk, such as through diet, exercise, and medication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
a day ago
- Metro
Like Jessie J, I was told I had early breast cancer
It is almost five years to the day since I heard those utterly unforgettable words on April 16, 2020: You have breast cancer. Sadly, I am far from alone. This morning, 37-year-old singer-songwriter and mother-of-one, Jessie J, revealed her own breast cancer diagnosis via Instagram. I recall my own experience so vividly. I remember screaming at the doctor that I was far too young, fit and healthy for this to be happening. Except it was happening. And to me. I was 41. At the time, my daughter was five, my son was 11 months, and we had just gone into the first Covid lockdown. Half a decade on, hard as I try hard to crack on with life, reading Jessie J's news brings it all flooding back. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video While I was told that I had triple negative breast cancer – sometimes described as a faster-growing type – I was also told, like Jessie, that it had been discovered 'early.' Once you've found out you've got breast cancer, it's hard to seek solace in almost anything. Yet I was able to take at least a little comfort from medics repeatedly telling me that if you are diagnosed early (known as 'stage 1 to 2'), the disease is often highly treatable. Early breast cancer is more commonly known as stage 1 or 2 breast cancer. Stage 1 or 2 breast cancer is then further divided into stages 1A, 1B, 2A and 2B. Which stage you are diagnosed with depends on whether the cancer is bigger than 2cm or 5cm, and whether it has spread to the lymph nodes, how many and where. Common symptoms include a lump in the breast or armpit, skin dimpling or a change in texture, unusual nipple discharge, nipple changes, and changes in breast size or shape. You can find out more from Cancer Research UK here. Jessie herself has said she is 'holding on' to the word 'early'. The staging system is worked out based on certain factors, such as the size of the cancer, and whether it has spread to lymph nodes in the armpit. (Mine was a little bigger than 5cm overall, but very fortunately, hadn't spread). Prior to getting diagnosed, I was in really good health. I'd been vegetarian since the age of nine, had never smoked, and did exercise most days. There was also no family history of it. But as I have come to understand in the wake of all this, cancer does not discriminate, even when you're a world-famous celebrity. I, and Jessie, are simply two of the unlucky ones. I made the appointment to get myself checked out after finding a lump on my left breast while sitting in the bath a few weeks into lockdown. At the time, I remember thinking it was more just precautionary, as opposed to anything else. At first, even the consultant wasn't too concerned, suggesting it might just be a sporting injury. But the scans soon told a very different story. After going through a blur of mammograms and ultrasounds – and having several biopsies taken – it was confirmed that I was going to need chemotherapy, radiotherapy and surgery. One of the toughest summers of my life followed. I underwent a gruelling four-month chemotherapy regime – consisting of Paclitaxel and Carboplatin – as well as an intense two-week course of daily radiotherapy. And in the midst of all that, I had an operation known as a 'therapeutic mammoplasty.' While this is not as major as a mastectomy, it is more involved than a lumpectomy. It essentially involves surgeons removing the tumour, but trying to save as much of the breast as possible. To paraphrase the words of Jessie J in her heart-wrenchingly honest and emotional Instagram video: 'I got to keep my nipples.' In October 2020, I got the 'all-clear' (or at least the closest thing you get to an 'all-clear' as far as cancer is concerned – as once you've had this disease, you never really get to walk away). All I can say to Jessie J – and anyone going through any version of this gruelling journey right now – is that I am forever grateful to my body for making it through all of this. It may look a little different these days, but I am still here – working full-time, being a mum to two high-octane kids now aged nine and six, playing netball, lifting weights, sea swimming and so much more – and I have my body to thank for that. I have also learned to love my boobs all over again. Jessie J mentioned how she had gone 'back and forth' on sharing her story. Having gone through this life-changing experience, I applaud her bravery and honesty. I am always keen to share mine because by opening myself up and by being vulnerable and brutally honest, I hope I can show the solidarity Jessie speaks of, and maybe even offer a little help to others going through something similar. I also believe that if reading my story gets even one woman to do a breast examination or schedule an appointment, then some good has come out of all I've been through. I can't say it bluntly enough: Checking your boobs could save your life. Hard as it is to write these words, catching breast cancer in its early stages really can be the difference between surviving – and not. Get a tumour removed at an early stage, and there's a far better chance of things going well. In April this year, I reached my fifth year since diagnosis, a not insignificant milestone in my journey, as doctors say that at this stage post treatment, the risk seems to go back down (though the increased risk does not go away completely). More Trending To mark this five-year anniversary, I did a host of fundraising events, including a 'Mighty Hike' along the Cornish coast in aid of Macmillan Cancer Support, raising almost £3,000. And, on April 16 itself, I went to the beach – here, where I live, in beautiful north Devon – with my husband and children, and watched the waves lap against the shore. I also hugged them all hard. Very, very hard. View More » I hope and wish that Jessie J will get to do the same. Do you have a story you'd like to share? Get in touch by emailing Share your views in the comments below. MORE: Women who have a miscarriage in West Virginia could be prosecuted MORE: The words I wish I could say to my 17-year-old closeted self MORE: I'm on benefits – landlords refuse to rent to me Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
The Independent
a day ago
- The Independent
Cancer deaths drop by a fifth in 50 years – but cases are on the rise
Cancer death rates in the UK have seen a significant decline of over 20 per cent since the early 1970s, a new analysis reveals. According to a report by Cancer Research UK, while cancer diagnoses are on the rise, the likelihood of dying from the disease has decreased. The cancer death rate has fallen by approximately 22 per cent since 1973, dropping from 328 per 100,000 people to around 252 per 100,000 in 2023. This improvement is largely due to advancements in diagnosis and treatment, along with successful efforts to reduce smoking rates. However, the report also indicates that cancer diagnoses have increased by almost half (47 per cent) across Great Britain during the same period. The rate has risen from approximately 413 cases per 100,000 people to around 607 cases per 100,000 people. The study noted that "survival for all cancers combined in England and Wales has doubled since the early 1970s, but progress has slowed over the last 10 years and remains lower than other comparable countries," also stating that "survival increased three to five times faster in previous decades, compared with the improvement since 2010." Michelle Mitchell, Cancer Research UK's chief executive, said the findings show 'it is a time of both optimism and realism,' adding that it is also 'a golden age for cancer research.' The group's report cautions that, despite improvements in overall survival rates, the number of people being diagnosed with cancer has significantly increased compared to 50 years ago. Researchers identified smoking as the leading preventable cause of cancer, with obesity linked to 13 different types of the disease. Other risks include not using sunscreen or failing to cover up in the sun, sunbeds, alcohol, lack of exercise and diets high in processed meat. The report pointed out that around half of all new cancer diagnoses are in people aged 70 and over, but incidence rates are currently rising fastest in younger people. It said: 'In the UK, cancer incidence rates have increased by 23 per cent in people aged 20 to 49 since the early 1990s. 'However, population growth is concentrated in older age groups, so in terms of patient numbers, the biggest increase in cancer cases has been in older people.' The study also found that, on average, just over half of cancers are diagnosed at an early stage in England (54 per cent), and this proportion has not changed for almost a decade. Ms Mitchell said: 'It's fantastic to see that thanks to research, cancer death rates have drastically reduced over the last 50 years, and survival has doubled. 'However, there's more that can be done. This report highlights that over 460 people die from cancer every single day in the UK, and too many cases are diagnosed at a late stage. 'If we want to change that, we need bold action from the UK Government. 'The upcoming National Cancer Plan for England must improve cancer survival, and transform cancer services. 'If this plan is done right, it could save countless lives across England and ensure people affected by cancer live longer, better lives.' Cancer Research UK is calling for commitments such as the national rollout of a targeted lung cancer screening programme, quicker access to diagnostic tests for all patients, better access to GPs for speedy diagnosis and action to improve cancer waiting times. Its new study is the first ever to include 50 years of cancer death and incidence data for the UK. Elsewhere, MPs and members of the House of Lords have urged the Government to prioritise faster diagnosis of less survivable cancers, which are those that develop in the brain, pancreas, liver, lung, oesophagus and stomach. A new report from the All-Party Parliamentary Group (APPG) on Less Survivable Cancers claims these cancers claim 67,000 lives a year, around 42 per cent of cancer deaths. Doubling diagnoses rates in these areas could save an additional 7,500 lives a year, it said. Paulette Hamilton, chairwoman of the APPG on Less Survivable Cancers, said this is a 'crucial moment for transforming patient outcomes and accelerating survival rates for the less survivable cancers'. 'We're on the brink of research breakthroughs and in the midst of developing potentially game-changing Government health reforms,' she added. 'In this backdrop, achieving faster diagnosis for these devastating cancers is finally within reach.' Professor Peter Johnson, NHS national clinical director for cancer, said: 'The NHS is seeing and treating record numbers of people for cancer, with more people diagnosed at an earlier stage than ever before, and survival rates in England at an all-time high. 'We have developed world-leading programmes, including lung cancer screening in convenient locations such as car parks and using AI to spot skin cancer, making it easier than ever before to get checked. 'The latest data shows that more than three quarters of people received the all-clear or a definitive cancer diagnosis within four weeks of an NHS urgent cancer referral.'
The Independent
2 days ago
- The Independent
Brits more likely to develop cancer but less likely to die: report
Cancer death rates in the UK have fallen by 22 per cent since the early 1970s, but cancer diagnoses have increased by 47 per cent in Great Britain during the same period, according to Cancer Research UK. The decline in cancer deaths is attributed to advancements in diagnosis and treatment, as well as initiatives to reduce smoking. Michelle Mitchell, Cancer Research UK 's chief executive, described the findings as a time of 'optimism and realism,' highlighting that it is also 'a golden age for cancer research'. Smoking is identified as the leading preventable cause of cancer, with obesity linked to 13 different types of the disease. MPs and members of the House of Lords are urging the Government to prioritise faster diagnosis of less survivable cancers, which account for approximately 42 per cent of cancer deaths.
